Crawley, United Kingdom

Neil Pritchard

This inventor holds 1 USPTO granted patent. Top assignee: Elekta, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Pritchard. Retrieved from https://idiyas.com/inventor/neil-pritchard-fnfv1bv1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil Pritchard: Innovator in Radiotherapy Technology

Introduction

Neil Pritchard is a notable inventor based in Crawley, GB. He has made significant contributions to the field of radiotherapy through his innovative patent. His work focuses on enhancing the safety and efficacy of radiotherapy devices used in medical treatments.

Latest Patents

Neil Pritchard holds a patent for a method related to radiotherapy devices and access authorization. This patent outlines a method for determining whether a radiotherapy device, configured to provide therapeutic radiation to a patient, should be authorized for use. The device consists of multiple components, each equipped with an identifier that provides data identifying the component. The method involves receiving data from these identifiers, assessing whether authorization criteria are met, and determining if the device is authorized for use based on this data.

Career Highlights

Neil Pritchard is associated with Elekta, Inc., a company renowned for its advancements in radiotherapy technology. His work at Elekta has positioned him as a key player in the development of innovative solutions that improve patient care in oncology.

Collaborations

Neil collaborates with talented professionals in his field, including Paul Boxall and Colin Raymond Winfield. These collaborations enhance the development of cutting-edge technologies in radiotherapy.

Conclusion

Neil Pritchard's contributions to radiotherapy technology through his patent and work at Elekta, Inc. highlight his commitment to improving patient outcomes in cancer treatment. His innovative approach continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…